<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
	<title>Medicinal Chemistry</title>
	<meta name='Generator' content='Zim 0.73.1'>
	<style type='text/css'>
		a          { text-decoration: none      }
		a:hover    { text-decoration: underline }
		a:active   { text-decoration: underline }
		strike     { color: grey                }
		u          { text-decoration: none;
					 background-color: yellow   }
		tt         { color: #2e3436;            }
		pre        { color: #2e3436;
					 margin-left: 20px          }
		h1         { text-decoration: underline;
					 color: #4e9a06; margin-bottom: 0 }
		h2         { color: #4e9a06; margin-bottom: 0 }
		h3         { color: #4e9a06; margin-bottom: 0 }
		h4         { color: #4e9a06; margin-bottom: 0 }
		h5         { color: #4e9a06; margin-bottom: 0 }
		p          { margin-top: 0              }
		span.zim-tag {
			color: #ce5c00;
		}
		div.zim-object {
			border-style:solid;
			border-width:1px;
		}
		.checked-box {list-style-image: url(data:image/png;base64,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)}
		.xchecked-box {list-style-image: url(data:image/png;base64,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)}
		.unchecked-box {list-style-image: url(data:image/png;base64,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)}
		.migrated-box {list-style-image: url(data:image/png;base64,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)}
		ul {list-style-image: none}
		/* ul rule needed to reset style for sub-bullets */
	</style>
</head>
<body>

<!-- Header -->
<div class='header'>
	[ <a href='..\8.html'>Prev</a> ]

	[ <span class='insen'>Index</span> ]

	[ <a href='./Pharmacognosy.html'>Next</a> ]
</div>

<hr />

<!-- Wiki content -->

<div class='pages'>
	<div class='heading'>
	<h1>Medicinal Chemistry <a name='8:Medicinal Chemistry'></a></h1>
	</div>

	<div class='content'>
	<h1>Tetracyclins, amphenicols, aminoglycosides, macrolides, lincosamides</h1>

<br>
<br>

<h1>Macrolide antibiotics</h1>

<p>
→  characteristic large lactone ring  <br>
<ul>
<li>have two or more characteristic sugars (usually cladinose and desosamine attached  14-membered ring</li>
<li>carries a substituted amino group → weakly basic</li>
</ul>
→ not ver water soluble → salt formations with acids(glucoheptonic + lactobiononic acids)<br>
→ biosynthesized from propionic acid units (every second carbon of erythromycin(<br>
<ul>
<li>bears a mthexyl group and the rest rings are oxygen bearing</li>
<li>two carbons so called "extra"oxygen introduced later in the biosynthesis and 2 hydroxyl are glycosylated</li>
</ul>
</p>

<p>
→ early macrolides →  are chemically unstable because of rapid acid-catalyzed internal cyclic ketal formation, leading to inactivity <br>
<ul>
<li>administered in coated tablets </li>
</ul>
</p>

<p>
⇒ Macrolides Site and mechanism of action •Proteosynthesis inhibition •act at 50S ribosome subunit •inhibit the translocation of growing peptide from acceptor (A) to peptide (P) site •bacteriostatic effect Spectrum: •both G+ and GNeisseria, Haemophillus, Brahmanella, Legionella …
</p>

<h3>CLARITHROMYCIN</h3>

<p>
→ C-6 converted semi to methel ether<br>
<ul>
<li>more lipophilic → prevent ketal fromation <i> better blood levels </i> less gastric upset</li>
</ul>
→ after first pass liver metabolism → C-14 hydroxy analogue → greater antimicrobial potency (Haemophilus influenzae)<br>
<img src="./Medicinal_Chemistry/pasted_image.png">
</p>

<h3>AZITHROMYCIN</h3>

<p>
→ called azalide,semisynthetic<br>
→ 15-membered lactone ring<br>
→ an N-methyl-group inserted between C9-C10 and carbonyl moiety is absent<br>
→ does not form a cyclic internal ketal<br>
→ more stable to acid/longer-half-life//greater and longer tissue penetration from erythromycin<br>
<ul>
<li>(first day 2 tablets and for the follwoing 5 1 tbls)</li>
</ul>
→ post antibiotic effect against some pathogans<br>
→ first choice of treatment among macrolides<br>
<img src="./Medicinal_Chemistry/pasted_image001.png">
</p>

<h3>TELITHROMYCIN:</h3>

<p>
→ orally effective<br>
→ treatment of community-asquired pneumonia,acute bacterial excebrations of chronic bronchitis,acute sinusitis.<br>
→ removal of the L-cladonise sugar at C-3 (which associated with the release of motilin and the resulting GI discomfort.<br>
→ oxidation of the free hydroxy group to a nonpolar ketone → ↓ biologocial activity through reducing the binding on domain V BUT<br>
<ul>
<li>offset by the addition of the chain at C-11/12 → greatly improves binding to domain II. ⇒  ↓ bacterial resistance</li>
</ul>
→ C-6 methoxy ↑ acid stability<br>
<img src="./Medicinal_Chemistry/pasted_image002.png">
</p>

<h1>AMINOPHENOLS( Chloramphenicol group)</h1>

<p>
→ isolated from Streptomyces venezuelae <br>
→•spectrum: both G+ and G-, e.g. Salmonella, Ricketsia, Bordetella pertussis, Neisseria, Haemophilus, Klebsiela, Enterobacter, Staphylococcus aureus, Streptococcus ... <br>
→ <b>mode of action</b>: proteosynthesis inhibition: blocks peptidyltransferase <br>
→ verse effect: irreversible aplastic anaemia ⇒ systemic use strongly limited <br>
→ phthalmo-chloramphenicol //  Spersadex gtt. opht. 
</p>

<p>
⇒ <b>R1</b> = -NO2 <b>R2</b> = -CHCl2 <b>chloramphenicol</b> <br>
⇒ <b>R1</b> = -NO2 <b>R2</b> = -CH2N3 <b>azidamphenicol</b> <br>
⇒ <b>R1</b> = CH3SO2 - <b>R2</b> = -CHCl2 <b>thiamphenicol</b> <br>
<img src="./Medicinal_Chemistry/pasted_image003.png">
</p>

<h2>Structure-activity relationships (SAR) in amphenicols</h2>

<p>
<img src="./Medicinal_Chemistry/pasted_image004.png"><br>
→ Chloramphenicol prodrugs optimized for particular ways of administration<br>
<ul>
<li>loramphenicol sodium succinate Chloramphenicoli natrii succinas PhEur Chloramphenicol ICN plv. inj. sol</li>
<li>chloramphenicol palmitate Chloramphenicoli palmitas PhEur nearly insoluble in water, bitter taste suppressed</li>
</ul>
</p>

<p>
→ 
</p>

<h1>LINCOSAMIDES</h1>

<p>
→ unusual 8-carbon sugar <a href="" title="+" class="page">+</a> thiomethyl amino-octoside linked by an amide bond to an n-propyl-substitued N-methylpyrrolidycarboxylic acid<br>
→ weakly basic and form hydrochloric acid salts<br>
→ chemically dinsticly from the macrolides but possess same moa<br>
→ mutually corss-resistance with macrolides<br>
→ extensive live metabolism → resulting primarly N-demethylation (analogues remain biological active)<br>
<img src="./Medicinal_Chemistry/pasted_image005.png">
</p>

<h3>LINCOMYCIN</h3>

<p>
→ fermantation of Streptomyces lincolnesis (now prepared synthetically )<br>
→ spectrum: both G+ and G-, e.g. Salmonella, Ricketsia, Bordetella pertussis, Neisseria, Haemophilus, Klebsiela, Enterobacter, Staphylococcus aureus, Streptococcus ...<br>
→ active against G+/anaerobes/<br>
→ reserved for patients who are allergic to penicillin<br>
→ starting material of clindamycin (by Sn-2 reaction that intervs the R stereochemistry of the c-7 hydroxyl to ca c-7 S-chloride)
</p>

<h3>CLINDAMYCIN</h3>

<p>
→ substitution of the chloride for the hydroxy group → ↑ bioactive and lipophilic → 90% absorbed via orall admn.<br>
→ C-2 phosphate ester pro-drugs → less painful for IM admin. than lincomycin<br>
→ G+ coccial and espesially in patients that are allergic on β-lactams<br>
→ GI compaints (nausea,vommiting,cramps)
</p>

<h1>AMINOGLYCOSIDES</h1>

<p>
→ contain a pharmacophoric- 1,3-diaminoinositol moiety (spectrum,potency,toxicity,pharmacokinetics are function of the specific identity to this unit)<br>
<ul>
<li>consisitng either by   streptamine (2-deoxystreptamine)</li>
<li>spectinamine</li>
</ul>
→ several of alcocholic diaminoinositol are subed through glycosidic bond with characteristic amino sugars to form psudo-oligosaccharides<br>
→ water soluble, basic and form addition salts <br>
→ does not absorbed in significant amounts from the GIT<br>
→ exrected via urine in active form and high concentration<br>
→ more commonly given IM/PERF<br>
→ toxicity potential limits clinical use<br>
→ widely distributed <a href="" title="+" class="page">+</a> low levels of protein binding.<br>
<img src="./Medicinal_Chemistry/pasted_image006.png">
</p>

<h1>STREPTOMYCIN</h1>

<p>
→ fermentation of Streptomyces girseus<br>
→ treatment of turbeculosis<br>
→ modifed pharmacophore is that the diaminoinositol unit is streptamine<br>
→ also has axial hydroxyl groyp at c-2 + two highly basic guanido group at c-1 + c-3 primary amine<br>
→ resistance due to n-acetylation 0-phosphorilation O adenyltaion of specific functional group<br>
<img src="./Medicinal_Chemistry/pasted_image007.png">
</p>

<h3>NEOMYCIN GROUP</h3>

<p>
→ mixture of three compounds produced by fermentation of Streptomyces fradiae [ neomycin B predominating.]<br>
→  preoperative bowel sanitation and the treatment of enteropathogenic Escherichia coli infections
</p>

<h3>KANAMYCIN GROUP (kanamycin,amikacin,tobramycin,gentamaycin,sisomycin,netilmycin)</h3>

<br>

<p>
<b>KANAMYCIN</b><br>
→ mixture of at least three components [A,B,C,with A predomination]<br>
→ isolated from Streptomyces kanamycetius<br>
→ most chemically stable<br>
→ heated without loss of activity in acidic+alkaline solutions<br>
→ unstablet o-R-factor enzymes<br>
→ O-phosphorylated on C-3 hydroxyl by enzymes APH3-I and APH3-II<br>
<ul>
<li>N-acetylated on C-6 amino group                                                           [antibiotically active]</li>
</ul>
</p>

<p>
<b>AMIKACIN</b><br>
→ semi-synthetically from kanamycin A<br>
→ L-hydroxyaminobutyryl amide moeity attached N-3 <br>
<ul>
<li>inhibit adenylation and phosphorylation in the distant amino sugar ring (C-2/C-3) even if it's not the ezymatmic reaction site</li>
<li>↓ R-factor mediated enzymes, ↑ potency &amp; spectrum</li>
</ul>
</p>

<p>
<b>tTOBRAMYCIN</b><br>
→ mixtured produces by fermentation of Streptomyces tenebrarius<br>
→ lacking c3 hydroxyl group
</p>

<p>
<b>GENTAMYCIN</b><br>
→ mixture of several antibiotic components produces by Micromonospora purpurea<br>
→ C-1,C-2 and C-1a are the mostos prominent<br>
→ most importan aminoglycoside antibiotic still in use<br>
→ some functionals groups that servers as targets on R factor mediated enzymes are missing → ↑ antibacterial enhance<br>
→ C-2' adenylation C-6' acetylation,C-1,C-2<br>
→ react with each other with β-lactam ( N-acetylation on C-1) → inactivating both antibiotics.
</p>

<p>
S<b>pectinomycin (Trobicin</b><br>
→ unusual aminoglycoside antibiotic<br>
→ fermentantion of Streptomyces spectabillis<br>
→ diaminoinositl unti contains <br>
<ul>
<li>two mono-N-methyl groups</li>
<li>hydroxyl opposite stereochemistry than streptomycin</li>
</ul>
→ glycosidically attached sugar is also unusual that contain 3 carbonyl groups and is fused by two adjacent linkages to spectinamine<br>
(three-ring structures)<br>
→ bacteriostatic<br>
<img src="./Medicinal_Chemistry/pasted_image008.png"><br>
<img src="./Medicinal_Chemistry/pasted_image009.png">
</p>


	</div>

	<br />

	<div class='page-footer'>

			<b>Attachments:</b>
			<table>

			<tr><td><a href='./Medicinal_Chemistry/pasted_image.png'>pasted_image.png</a></td><td>&nbsp;</td><td>35.7kb</td></tr>


			<tr><td><a href='./Medicinal_Chemistry/pasted_image001.png'>pasted_image001.png</a></td><td>&nbsp;</td><td>112kb</td></tr>


			<tr><td><a href='./Medicinal_Chemistry/pasted_image002.png'>pasted_image002.png</a></td><td>&nbsp;</td><td>84.3kb</td></tr>


			<tr><td><a href='./Medicinal_Chemistry/pasted_image003.png'>pasted_image003.png</a></td><td>&nbsp;</td><td>15.0kb</td></tr>


			<tr><td><a href='./Medicinal_Chemistry/pasted_image004.png'>pasted_image004.png</a></td><td>&nbsp;</td><td>231kb</td></tr>


			<tr><td><a href='./Medicinal_Chemistry/pasted_image005.png'>pasted_image005.png</a></td><td>&nbsp;</td><td>169kb</td></tr>


			<tr><td><a href='./Medicinal_Chemistry/pasted_image006.png'>pasted_image006.png</a></td><td>&nbsp;</td><td>115kb</td></tr>


			<tr><td><a href='./Medicinal_Chemistry/pasted_image007.png'>pasted_image007.png</a></td><td>&nbsp;</td><td>31.7kb</td></tr>


			<tr><td><a href='./Medicinal_Chemistry/pasted_image008.png'>pasted_image008.png</a></td><td>&nbsp;</td><td>15.6kb</td></tr>


			<tr><td><a href='./Medicinal_Chemistry/pasted_image009.png'>pasted_image009.png</a></td><td>&nbsp;</td><td>83.8kb</td></tr>

			</table>
	</div>

	

</div>

</body>
</html>
